- Report
- January 2026
- 194 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 190 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 184 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 196 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 185 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 191 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- April 2026
- 200 Pages
Global
From €2675EUR$2,990USD£2,292GBP
- Report
- February 2026
Global
From €4383EUR$4,900USD£3,756GBP
- Report
- October 2025
Global
From €4383EUR$4,900USD£3,756GBP
- Report
- September 2026
- 180 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 190 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 187 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 190 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 191 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 183 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 196 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 185 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- March 2026
- 150 Pages
Global
From €5323EUR$5,950USD£4,560GBP
- Report
- May 2026
- 140 Pages
Global
From €5323EUR$5,950USD£4,560GBP
- Report
- November 2025
- 150 Pages
Global
From €5323EUR$5,950USD£4,560GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more